Dirk R Larson

15PUBLICATIONS

85CO-AUTHORS

Inorganic materials (incl. nanomaterials)BiomechanicsMedical mycologyHaematological tumoursMedical infection agents (incl. prions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|May 25, 2026

Prevalence of monoclonal gammopathy of undetermined significance (MGUS) using a sensitive mass spectrometry assay in young individuals 10-49 years of age: a population-based study from the National Health and Nutritional Examination Survey.

|Mar 31, 2026

Primary total knee arthroplasty for primary and secondary osteonecrosis : reliable outcomes at 15 years.

Nils Meissner, Matthew T Weintraub, Dirk R Larson

|Jan 07, 2026

POD24 is a novel determinant of prognosis in patients with Waldenström macroglobulinemia.

Saurabh Zanwar, Jithma Abeykoon, Shirley D'Sa

|May 07, 2025

BLAST: a globally applicable and molecularly versatile survival model for chronic myelomonocytic leukemia.

Ayalew Tefferi, Saubia Fathima, Maymona Abdelmagid

|Nov 06, 2024

Multicenter Randomized Clinical Trial of Highly Cross-Linked Polyethylene Versus Conventional Polyethylene in 518 Primary TKAs at 10 Years.

Harold I Salmons, Dirk R Larson, Cedric J Ortiguera

|Oct 22, 2024

Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detection.

Alissa Visram, Dirk Larson, Aaron Norman

Pageof 3

Frequent Collaborators

Angela Dispenzieri

Shaji Kumar

Matthew P Abdel

Celine Vachon

Rafael J Sierra

Susan Slager

Robert T Trousdale

Vincent Rajkumar

Mark W Pagnano

Michael J Taunton

Frequent Collaborators

Angela Dispenzieri

Shaji Kumar

Matthew P Abdel

Celine Vachon